Oseltamivir Phosphate
Product Images NDC 53002-6387

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 53002-6387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oseltamivirphosphatecamberlogo1 (Oseltamivirphosphatecamberlogo1)

FDA Label Image

Oseltamivirphosphatecamberlogo2 (Oseltamivirphosphatecamberlogo2)

FDA Label Image

Oseltamivirphosphatestructure (Oseltamivirphosphatestructure)

Oseltamivirphosphatestructure (Oseltamivirphosphatestructure)
Chemical structure of Oseltamivir Phosphate shown as a molecular formula diagram with atoms and bonds illustrating its chemical composition along with a phosphate group (H3PO4).*
FDA Label Image

Label Image (Lbl530026387)

Label Image (Lbl530026387)
Oseltamivir Phosphate 75 mg Capsules packaging label from RPK Pharmaceuticals, Inc. The label directs taking one capsule twice a day for 5 days or as directed. It specifies 10 capsules per package and includes prescription and pharmacy information sections.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.